Vera Therapeutics Inc at TD Cowen Healthcare Conference Transcript
Hi, everyone. Thank you for joining us today at the Vera fireside chat. I'm covering analyst Ritu Baral from TD Cowen at the TD Cowen Healthcare Conference. And joining us from Vera, this is a very incomplete list, we have CEO Marshall Fordyce. We have our CFO and our new Chief Commercial Officer as well. Welcome, Matt. Welcome, Sean.
Questions & Answers
So ongoing FDA review. Obviously, you guys have submitted the Atacicept application. It has been accepted. And you have your July 7 PDUFA with priority review. The data package seems awfully straightforward. What's left to discuss as review issues for your mid-cycle? I mean, we've talked about the label and stuff like that, but that seems like a labeling thing. So what are points of potential FDA focus?
Great. Great to be here, Ritu. Thanks so much. PDUFA date is July 7. We
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
